Because the effect of LY294002 is known to be mediated through the inhibition of PI3K/Akt/mammalian target of Rapamycin (mTOR) [40], these cell-survival factors are thought to produce an effective action as inhibitors of apoptosis in SS. The gene discussed is MTOR; the disease is synovial sarcoma.